YEM Search

Plant Summary

Plant Information

TCMBANKHE005900

TCMBank_ID:	TCMBANKHE005900
YEM_ID:	YEM-265
ID:	TCMBANKHE005900/YEM-265
植物拉丁名:	Eriobotrya japonica\|Eriobotrya japonica (Thunb.)Lindl.
功能与主治:	To moisten lung and precipitate qi, allay thirst./Lung heat cough asthma, vomiting of sour matter, vexation and thirst.
药用植物名:	枇杷
药名:	枇杷
来源:	云南民族药物志：第二卷
药用部位:	fruit
使用民族:	阿昌族/傣族/德昂族/景颇族/傈僳族/水族/彝族
TCM_ID_id:	4713

植物对应的化合物

化合物ID	化合物名	别名	分子式	分子质量	Smiles

TCMBANKIN040021	farnesiferol a	7-{[(1S,4AS,6R,8AR)-6-HYDROXY-5,5,8A-TRIMETHYL-2-METHYLIDENE-HEXAHYDRO-1H-NAPHTHALEN-1-YL]METHOXY}CHROMEN-2-ONE; SCHEMBL12362728; 7-[[(1S,4aS,6R,8aR)-6-hydroxy-5,5,8a-trimethyl-2-methylidene-3,4,4a,6,7,8-hexahydro-1H-naphthalen-1-yl]methoxy]chromen-2-one; 8YC9944MPJ; UNII-8YC9944MPJ; Farnesiferol A, >=85% (NMR); 511-33-1; DTXSID00199105; ZINC4081322; Farnesiferol A; Mogoltadin; NCGC00385155-01!7-[[(1S,4aS,6R,8aR)-6-hydroxy-5,5,8a-trimethyl-2-methylidene-3,4,4a,6,7,8-hexahydro-1H-naphthalen-1-yl]methoxy]chromen-2-one; MolPort-002-525-707; CHEMBL1078138; AC1OF2BZ	C24H30O4	382.5 g/mol	CC1(C2CCC(=C)C(C2(CCC1O)C)COC3=CC4=C(C=C3)C=CC(=O)O4)C
TCMBANKIN042231	amygdalin	(2R)-2-phenyl-2-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxyacetonitrile; (2R)-2-phenyl-2-[[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)-2-tetrahydropyranyl]oxymethyl]-2-tetrahydropyranyl]oxy]acetonitrile; (2R)-2-phenyl-2-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-methylol-tetrahydropyran-2-yl]oxymethyl]tetrahydropyran-2-yl]oxy-acetonitrile; ethane; 2-(hydroxymethyl)-6-[[6-(methoxymethyl)-3,4,5-tris(oxidanyl)oxan-2-yl]methoxymethyl]oxane-3,4,5-triol; methanenitrile; methylbenzene; molecular hydrogen; (2R)-2-phenyl-2-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxy-ethanenitrile; C08325; CHEBI:17019; (2R)-2-phenyl-2-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxymethyl]tetrahydropyran-2-yl]oxy-acetonitrile; 29883-15-6; STOCK1N-52529; (-)-D-mandelonitrile beta-D-gentiobioside; (2R)-[(6-O-beta-D-glucopyranosyl-beta-D-glucopyranosyl)oxy](phenyl)acetonitrile; A820093; SMP1_000103; Amygdalin; ethane; formonitrile; 2-(hydroxymethyl)-6-[[3,4,5-trihydroxy-6-(methoxymethyl)-2-oxanyl]methoxymethyl]oxane-3,4,5-triol; molecular hydrogen; toluene	C20H27NO11	457.43	C1=CC=C(C=C1)C(C#N)OC2C(C(C(C(O2)COC3C(C(C(C(O3)CO)O)O)O)O)O)O
TCMBANKIN045916	phytofluene		C40H62	543	C(/C([H])([H])[H])(\C([H])([H])[H])=C([H])/C([H])([H])C([H])([H])\C(\C([H])([H])[H])=C([H])\C([H])([H])C([H])([H])\C(\C([H])([H])[H])=C([H])\C([H])=C([H])\C(\C([H])([H])[H])=C([H])\C([H])=C([H])/C([H] )=C(/C([H])([H])C([H])([H])\C([H])=C(\C([H])([H])C([H])([H])\C([H])=C(\C([H])([H])C([H])([H])\C(\C([H])([H])[H])=C([H])/C([H])([H])[H])/C([H])([H])[H])/C([H])([H])[H])\C([H])([H])[H]
TCMBANKIN058839	Farnesol acetate	(2E,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-yl acetate; [(2E,6E)-3,7,11-trimethyldodeca-2,6,10-trienyl] acetate; acetic acid 3,7,11-trimethyldodeca-2,6,10-trienyl ester; InChI=1/C17H28O2/c1-14(2)8-6-9-15(3)10-7-11-16(4)12-13-19-17(5)18/h8,10,12H,6-7,9,11,13H2,1-5H3/b15-10+,16-12; 2,6,10-dodecatrien-1-ol, 3,7,11-trimethyl-, acetate, (2E,6E)-; All-trans-Farnesyl acetate; farnesol acetate; 4128-17-0; 3,7,11-Trimethyl-2,6,10-dodecatrienyl acetate; 340480_ALDRICH; 29548-30-9; NSC132958; AI3-33837; 2,6,10-Dodecatrien-1-ol, 3,7,11-trimethyl-, acetate; (E,E)-3,7,11-Trimethyl-2,6,10-dodecatrien-1-ol acetate; 3,7,11-Trimethyldodeca-2,6,10-trienyl acetate; [(2E,6E)-3,7,11-trimethyldodeca-2,6,10-trienyl] ethanoate; 2,6,10-Dodecatrien-1-ol, 3,7,11-trimethyl-, acetate, (E,E)-; (E,E)-3,7,11-Trimethyl-2,6,10-dodecatrien-1-yl acetate; acetic acid [(2E,6E)-3,7,11-trimethyldodeca-2,6,10-trienyl] ester; 3,7,11-Trimethyl-2,6,10-dodecatrien-1-ol acetate; 3,7,11-trimethyldodeca-2,6,10-trienyl ethanoate; trans,trans-Farnesyl acetate; 45895_FLUKA; EINECS 249-689-1; ZINC01719908; 3,7,11-Trimethyl-2,6,10-dodecatrien-1-yl acetate; NSC 132958;trans,trans-farnesyl acetate;Farnesyl acetate;Tox21_302688; AKOS025295075; (2E,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-yl acetate; ACM29548309; D5ZJ1FOC2I; [(2E,6E)-3,7,11-trimethyldodeca-2,6,10-trienyl] acetate; Farnesyl acetate, 95%, mixture of cis and trans; MolPort-002-135-206; trans-2-trans-6-Farnesyl acetate; (2E,6E)-3,7,11-Trimethyl-2,6,10-dodecatrienyl acetate; 162327-52-8; Farnesol acetate; ST50826011; UNII-D5ZJ1FOC2I; E,E-Farnesyl Acetate; Farnesyl acetate, mixture of isomers; S14-1289; (E,E)-farnesyl acetate; InChI=1/C17H28O2/c1-14(2)8-6-9-15(3)10-7-11-16(4)12-13-19-17(5)18/h8,10,12H,6-7,9,11,13H2,1-5H3/b15-10+,16-12; 2-trans-6-trans-Farnesyl acetate; MFCD00036516; acetic acid [(2E,6Z)-3,7,11-trimethyldodeca-2,6,10-trienyl] ester; TR-012831; 2,6,10-dodecatrien-1-ol, 3,7,11-trimethyl-, acetate, (2E,6E)-; Farnesyl acetate, technical, mixture of isomers; All-trans-Farnesyl acetate; LMFA07010230; [(E,E)-3,7,11-Trimethyl-2,6,10-dodecatriene-1-yl]ester of acetic acid; ZGIGZINMAOQWLX-NCZFFCEISA-N; (E)-Farnesyl acetate; DTXSID5047110; trans, trans-Farnesyl acetate; DSSTox_GSID_47110; farneoylacetate; 4128-17-0; 3,7,11-Trimethyl-2,6,10-dodecatrienyl acetate; trans,trans-Farnesyl acetate, 95%; Farnesyl acetate, (E,E)-; A819958; 29548-30-9; NSC132958; DSSTox_CID_27110; Acetic acid (6E)-3,7,11-trimethyl-2,6,10-dodecatrienyl ester; (cis,trans)-Farnesyl acetate; (E,E)-3,7,11-Trimethyl-2,6,10-dodecatrien-1-ol acetate; [(2E,6E)-3,7,11-trimethyldodeca-2,6,10-trienyl] ethanoate; AC1LCWI8; 2,6,10-Dodecatrien-1-ol, 3,7,11-trimethyl-, acetate, (E,E)-; UNII-2ARF3ZNJ1R component ZGIGZINMAOQWLX-NCZFFCEISA-N; (E,E)-3,7,11-Trimethyl-2,6,10-dodecatrien-1-yl acetate; acetic acid [(2E,6E)-3,7,11-trimethyldodeca-2,6,10-trienyl] ester; AC1Q65TN; J-500791; (2E,6Z)-1-Acetoxy-3,7,11-trimethyl-2,6,10-dodecatriene; trans,trans-Farnesyl acetate; farnesyl acetate; farnesyl acetate, No Antioxidant; [(2E,6Z)-3,7,11-trimethyldodeca-2,6,10-trienyl] ethanoate; 1192109-55-9; 3,11-Trimethyl-2,6,10-dodecatrienyl acetate; (2Z,6Z)-3,7,11-Trimethyl-2,6,10-dodecatriene-1-ol acetate; Farnesyl acetate, (2E,6E)-; (2E,6E)-Farnesyl acetate; trans2,trans6-Farnesyl acetate; DSSTox_RID_82120; 2,10-Dodecatrien-1-ol, 3,7,11-trimethyl-, acetate; NCGC00256905-01; CHEMBL3184169; ZINC1719908; CAS-4128-17-0; [(2E,6Z)-3,7,11-trimethyldodeca-2,6,10-trienyl] acetate; NSC-132958	C17H28O2	264.4 g/mol	CC(=CCCC(=CCCC(=CCOC(=O)C)C)C)C
TCMBANKIN058898	γ-camphorene	AC1NSTBW; gamma-camphorene; 5-(6-methylhepta-1,5-dien-2-yl)-1-(4-methylpent-3-enyl)cyclohexene;gamma-Camphorene; Cyclohexene, 5-(5-methyl-1-methylene-4-hexen-1-yl)-1-(4-methyl-3-penten-1-yl)-; Camphorene, m-; 5-(6-Methylhepta-1,5-dien-2-yl)-1-(4-methylpent-3-en-1-yl)cyclohex-1-ene; 1,5-Heptadiene, 6-methyl-2-[3-(4-methyl-3-pentenyl)-3-cyclohexen-1-yl]-; Cyclohexene, 5-(5-methyl-1-methylene-4-hexenyl)-1-(4-methyl-3-pentenyl)-; OIRFZVJHADZVMD-UHFFFAOYSA-N; m-Camphorene; Metacamphorene	C20H32	272.5 g/mol	CC(=CCCC1=CCCC(C1)C(=C)CCC=C(C)C)C
TCMBANKIN059532	(1R)-1, 7, 7-trimethyl-bicyclo[2.2.1]heptan-2-one		C10H16O	152.23 g/mol	CC1(C2CCC1(C(=O)C2)C)C

植物对应的疾病

疾病ID	病名	疾病类型	MeSH	参考文献

植物对应的靶点

靶点ID	基因名	基因别名	描述	染色体位置	Map_Location	基因类型